AZIMUT PHARMA SL
Company details
- Active NIF/CIF: B65775744
-
Telephone: Not available
-
Date of last BORME entry: 11/12/2015
-
Sector: Comercio al por mayor y al por menor. Excepto reparación de vehículos de motor
-
Address: Avinguda Diagonal, 456, 08006 Barcelona, Barcelona, España See in map
-
Website: Not available
-
Featured products:
More information on AZIMUT PHARMA SL
-
11/12/2015 | BORME act no.: 501355 | Register: BARCELONARevocaciones -
11/12/2015 | BORME act no.: 501355 | Register: BARCELONANombramientos
-
04/10/2012 | BORME act no.: 405044 | Register: BARCELONACambio de domicilio social
-
19/04/2012 | BORME act no.: 172154 | Register: BARCELONAConstitución
-
19/04/2012 | BORME act no.: 172154 | Register: BARCELONANombramientos
-
19/04/2012 | BORME act no.: 172154 | Register: BARCELONAOtros conceptos
Other information
The CIF of AZIMUT PHARMA SL is B65775744 and its current business status is active. Its economic sector is within the CNAE 4690 - Non-specialised wholesale trade. Its SIC classification is 5099 - Mercancías varias no perecederas.
AZIMUT PHARMA SL employs approximately Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona. To date, it has 3 registration charges. Its most recent announcement in the Borme was published on 11/12/2015 and its last deposit of ordinary annual accounts corresponds to the year -.
You can access the contact information of AZIMUT PHARMA SL, such as the telephone number, postal address, and website, in the Company Data section.
If you wish to obtain more information about AZIMUT PHARMA SL, you can review one of our available financial reports, the Annual Accounts of the company, or check if it has any registered payment incidents in the RAI delinquency file.
The financial, commercial, and legal information of AZIMUT PHARMA SL comes from official data sources and is automatically updated every day.
Do you want to know more about AZIMUT PHARMA SL??
Find out more about this company by consulting these reports:
